Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Facial pain
ADR ID BADD_A01600
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.08      Pain and discomfort NEC
08.01.08.012      Facial pain
Description A disorder characterized by a sensation of marked discomfort in the face. [CTCAE] Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES. [MeSH]
MedDRA Code 10016059
MeSH ID D005157
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Atypical face pain | Facial pain | Pain in face | Perioral pain | Eyebrow pain | Facial Pain | Face Pain | Pain, Face | Pain, Facial | Orofacial Pain | Pain, Orofacial | Neuralgic Facial Pain | Facial Pain, Neuralgic | Pain, Neuralgic Facial | Craniofacial Pain | Pain, Craniofacial | Myofacial Pain | Pain, Myofacial
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000273%
BADD_D00165Aripiprazole--
BADD_D00171Ascorbic acid0.000496%
BADD_D00290Botulinum toxin type a--
BADD_D00294Brimonidine0.000451%
BADD_D00306Budesonide--
BADD_D00312Bupropion0.000040%
BADD_D00330Cabozantinib0.000437%
BADD_D00349Capecitabine--
BADD_D00356Carbamazepine0.001599%
BADD_D00364Carboplatin0.000112%
BADD_D00410Celecoxib0.000169%
BADD_D00417Cetirizine--
BADD_D00474Cisplatin0.000112%
BADD_D00480Clarithromycin--
BADD_D00551Cyclosporine0.000674%
BADD_D00574Dalfampridine0.001184%
BADD_D00589Dasatinib0.000571%
BADD_D00609Deoxycholic acid0.001507%
BADD_D00621Desvenlafaxine0.000909%
BADD_D00653Diclofenac0.000056%
BADD_D00680Dimethyl fumarate0.004201%
BADD_D00685Dinutuximab--
BADD_D00734Duloxetine0.000027%
BADD_D00788Epoprostenol0.000222%
BADD_D00800Erlotinib0.000112%
BADD_D00809Escitalopram0.000028%
BADD_D00852Etonogestrel0.001599%
BADD_D00858Everolimus0.000336%
BADD_D00931Fluorouracil0.000625%
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages